Robert G. Feldman, M.D.

Affiliations: 
Neurology Boston University School of Medicine, Boston, MA 
Area:
Neurotoxicology, Parkinson's disease
Google:
"Robert G. Feldman, M.D., chairman, Neurology, Boston University School of Medicine"
Mean distance: 16.81 (cluster 11)
 
Cross-listing: Neuropathology Tree

Collaborators

Sign in to add collaborator
Nelson Butters collaborator UCSD
 (Retrograde amnesia in Parkinson's disease.)
Roberta F. White collaborator BU School of Medicine
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ratner MH, Farb DH, Ozer J, et al. (2014) Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33
Hauser RA, Lew MF, Hurtig HI, et al. (2009) Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 564-73
Biglan KM, Schwid S, Eberly S, et al. (2006) Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23
Karamohamed S, Golbe LI, Mark MH, et al. (2005) Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91
Ellis T, de Goede CJ, Feldman RG, et al. (2005) Efficacy of a physical therapy program in patients with Parkinson's disease: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation. 86: 626-32
Karamohamed S, DeStefano AL, Wilk JB, et al. (2003) A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61
Miller JW, Selhub J, Nadeau MR, et al. (2003) Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology. 60: 1125-9
Feldman RG. (2003) Neurotoxic Manifestations of Exposure to Metals Office Practice of Neurology: Second Edition. 1287-1293
Wiesman JF, Feldman RG. (2003) Drug-Induced Peripheral Neuropathies Office Practice of Neurology: Second Edition. 626-633
Siderowf A, Stern M, Shoulson I, et al. (2002) A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943
See more...